Martingale Asset Management L P Sarepta Therapeutics, Inc. Transaction History

Martingale Asset Management L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$72.25 - $168.95 $274,622 - $642,178	-3,801 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$125.56 - $178.74 $163,479 - $232,719	-1,302 Reduced 25.51%	3,801 $648,000
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $139,704 - $189,401	1,099 Added 27.45%	5,103 $716,000
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $372,372 - $687,486	4,004 New	4,004 $642,000
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $415,513 - $562,670	-3,703 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$106.67 - $151.68 $394,999 - $561,671	3,703 New	3,703 $0
Q2 2018 Aug 09, 2018	SELL	$71.74 - $153.69 $760,946 - $1.63 Million	-10,607 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$54.02 - $82.27 $572,990 - $872,637	10,607 New	10,607 $0

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.